Kyeong Lee

Emailkayleedonggukedu

h-index

Research activity per year

Fingerprint

Dive into the research topics where Kyeong Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

207 Article
32 Review article
3 Comment/debate

Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity (Experimental & Molecular Medicine, (2022), 54, 9, (1450-1460), 10.1038/s12276-022-00840-x)
Bae, S. H., Kim, J. H., Park, T. H., Lee, K., Lee, B. I. & Jang, H., Feb 2026, In: Experimental and Molecular Medicine. 58, 1, p. 300 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition
Han, T. H., Lee, J., Im, J. Y., Nada, H., Godesi, S., Kim, C., Seo, A., Hwang, I., Shin, S. A., Lee, G. S., Kim, M., Moon, J. H., Han, T. S., Won, M., Gong, Y. D., Ban, H. S. & Lee, K., 2026, (Accepted/In press) In: Journal of Advanced Research.
Research output: Contribution to journal › Article › peer-review

Open Access
Calcium(ii)-catalyzed [2+3] annulation of enynones: a sustainable approach to 9H-pyrrolo[1,2-a]indole frameworks
Kale, A., Rivonker, S. C., Kim, J. H., Hwang, J. Y., Choi, Y. & Lee, K., 29 Jul 2025, In: Chemical Communications. 61, 62, p. 11689-11692 4 p.
Research output: Contribution to journal › Article › peer-review
c-KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions
Rivonker, S. C., Nada, H., Jaemin, C., Kwon, Y. J. & Lee, K., Oct 2025, In: Archiv der Pharmazie. 358, 10, e70113.
Research output: Contribution to journal › Review article › peer-review
1 Scopus citations
Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening
Elkamhawy, A., Ammar, U. M., Kim, M., Gul, A. R., Park, T. J. & Lee, K., Feb 2025, In: Archives of Pharmacal Research. 48, 2, p. 150-165 16 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations

New Vaccines Study Findings Have Been Published by Researchers at Dongguk University (Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches)
Kim, H. W. & Lee, K.
20/12/24
1 item of Media coverage
Press/Media

Kyeong Lee

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity (Experimental & Molecular Medicine, (2022), 54, 9, (1450-1460), 10.1038/s12276-022-00840-x)

Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition

Calcium(ii)-catalyzed [2+3] annulation of enynones: a sustainable approach to 9H-pyrrolo[1,2-a]indole frameworks

c-KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions

Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening

New Vaccines Study Findings Have Been Published by Researchers at Dongguk University (Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches)

Kyeong Lee

Fingerprint

Collaborations and top research areas from the last five years

Research output

Author Correction: BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity (Experimental & Molecular Medicine, (2022), 54, 9, (1450-1460), 10.1038/s12276-022-00840-x)

Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition

Calcium(ii)-catalyzed [2+3] annulation of enynones: a sustainable approach to 9H-pyrrolo[1,2-a]indole frameworks

c-KIT Small Molecule Inhibitors as a Therapeutic Strategy for Melanoma: Clinical Insights, SAR, and Future Directions

Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening

Press/Media

New Vaccines Study Findings Have Been Published by Researchers at Dongguk University (Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches)